TL;DR
Investigating the dosimetric advantage of inverse planning optimization in locally advanced cervical cancer using high-dose-rate (HDR) brachytherapy (BT) compared with point A plan and geometric optimization (GO) found that IPO makes it possible to deliver a sufficient dose for the D90 of the HR-CTV while reducing OAR doses with smallerHR-CTV values.
AI-generated by Semantic Scholar